Publications

Found 4 results
Filters: Author is F.G.M. Rego  [Clear All Filters]
2012
H. R. Frigeri, Santos, I. C. R., Réa, R. R., Almeida, A. C. R., Fadel-Picheth, C. M. T., Pedrosa, F. O., Souza, E. M., Rego, F. G. M., and Picheth, G., Low prevalence of glucokinase gene mutations in gestational diabetic patients with good glycemic control, vol. 11, pp. 1433-1441, 2012.
American Diabetes Association (2010). Diagnosis and classification of diabetes mellitus. Diabetes Care 33 (Suppl 1): S62-S69. http://dx.doi.org/10.2337/dc10-S062 PMid:20042775 PMCid:2797383   American Diabetes Association (2011). Diagnosis and classification of diabetes mellitus. Diabetes Care 34 (Suppl 1): S62-S69. http://dx.doi.org/10.2337/dc11-S062 PMid:21193628 PMCid:3006051   Arden C, Harbottle A, Baltrusch S, Tiedge M, et al. (2004). Glucokinase is an integral component of the insulin granules in glucose-responsive insulin secretory cells and does not translocate during glucose stimulation. Diabetes 53: 2346-2352. http://dx.doi.org/10.2337/diabetes.53.9.2346 PMid:15331544   Ben-Haroush A, Yogev Y and Hod M (2004). Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet. Med. 21: 103-113. http://dx.doi.org/10.1046/j.1464-5491.2003.00985.x PMid:14984444   de la Iglesia N, Veiga-da-Cunha M, Van Schaftingen E, Guinovart JJ, et al. (1999). Glucokinase regulatory protein is essential for the proper subcellular localisation of liver glucokinase. FEBS Lett. 456: 332-338. http://dx.doi.org/10.1016/S0014-5793(99)00971-0   Ellard S, Beards F, Allen LI, Shepherd M, et al. (2000). A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia 43: 250-253. http://dx.doi.org/10.1007/s001250050038 PMid:10753050   Gloyn AL (2003). Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy. Hum. Mutat. 22: 353-362. http://dx.doi.org/10.1002/humu.10277 PMid:14517946   Greeley SA, Tucker SE, Worrell HI, Skowron KB, et al. (2010). Update in neonatal diabetes. Curr. Opin. Endocrinol. Diabetes Obes. 17: 13-19. PMid:19952737   Grundy SM, Cleeman JI, Daniels SR, Donato KA, et al. (2006). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr. Opin. Cardiol. 21: 1-6. http://dx.doi.org/10.1097/01.hco.0000200416.65370.a0 PMid:16355022   Hayashi K (1991). PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl. 1: 34-38. http://dx.doi.org/10.1101/gr.1.1.34 PMid:1842918   Hollingsworth DR and Grundy SM (1982). Pregnancy-associated hypertriglyceridemia in normal and diabetic women. Differences in insulin-dependent, non-insulin-dependent, and gestational diabetes. Diabetes 31: 1092-1097. PMid:6757021   Iynedjian PB (2009). Molecular physiology of mammalian glucokinase. Cell Mol. Life Sci. 66: 27-42. http://dx.doi.org/10.1007/s00018-008-8322-9 PMid:18726182 PMCid:2780631   Jetton TL, Liang Y, Pettepher CC, Zimmerman EC, et al. (1994). Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut. J. Biol. Chem. 269: 3641-3654. PMid:8106409   Knopp RH, Chapman M, Bergelin R, Wahl PW, et al. (1980). Relationships of lipoprotein lipids to mild fasting hyperglycemia and diabetes in pregnancy. Diabetes Care 3: 416-420. http://dx.doi.org/10.2337/diacare.3.3.416 PMid:7389557   Kousta E, Ellard S, Allen LI, Saker PJ, et al. (2001). Glucokinase mutations in a phenotypically selected multiethnic group of women with a history of gestational diabetes. Diabet. Med. 18: 683-684. http://dx.doi.org/10.1046/j.1464-5491.2001.00530.x PMid:11553210   Lahiri DK and Nurnberger JI Jr (1991). A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19: 5444. http://dx.doi.org/10.1093/nar/19.19.5444 PMid:1681511 PMCid:328920   Liang Z, Dong M, Cheng Q and Chen D (2010). Gestational diabetes mellitus screening based on the gene chip technique. Diabetes Res. Clin. Pract. 89: 167-173. http://dx.doi.org/10.1016/j.diabres.2010.04.001 PMid:20554072   Magnuson MA and Shelton KD (1989). An alternate promoter in the glucokinase gene is active in the pancreatic beta cell. J. Biol. Chem. 264: 15936-15942. PMid:2550428   Marcinkevage JA and Narayan KM (2011). Gestational diabetes mellitus: taking it to heart. Prim. Care Diabetes 5: 81-88. http://dx.doi.org/10.1016/j.pcd.2010.10.002 PMid:21106447   Matschinsky FM (2009). Assessing the potential of glucokinase activators in diabetes therapy. Nat. Rev. Drug. Discov. 8: 399-416. http://dx.doi.org/10.1038/nrd2850 PMid:19373249   Matschinsky FM and Ellerman JE (1968). Metabolism of glucose in the islets of Langerhans. J. Biol. Chem. 243: 2730-2736. PMid:4870741   Matschinsky FM, Magnuson MA, Zelent D, Jetton TL, et al. (2006). The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Diabetes 55: 1-12. http://dx.doi.org/10.2337/diabetes.55.01.06.db05-0926 PMid:16380470   Metzger BE, Phelps RL, Freinkel N and Navickas IA (1980). Effects of gestational diabetes on diurnal profiles of plasma glucose, lipids, and individual amino acids. Diabetes Care 3: 402-409. PMid:7190092   Metzger BE, Lowe LP, Dyer AR, Trimble ER, et al. (2008). Hyperglycemia and adverse pregnancy outcomes. N. Engl. J. Med. 358: 1991-2002. http://dx.doi.org/10.1056/NEJMoa0707943 PMid:18463375   Meyers-Seifer CH and Vohr BR (1996). Lipid levels in former gestational diabetic mothers. Diabetes Care 19: 1351-1356. http://dx.doi.org/10.2337/diacare.19.12.1351 PMid:8941463   Orita M, Iwahana H, Kanazawa H, Hayashi K, et al. (1989). Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. U. S. A. 86: 2766-2770. http://dx.doi.org/10.1073/pnas.86.8.2766 PMid:2565038 PMCid:286999   Osbak KK, Colclough K, Saint-Martin C, Beer NL, et al. (2009). Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum. Mutat. 30: 1512-1526. http://dx.doi.org/10.1002/humu.21110 PMid:19790256   Printz RL, Magnuson MA and Granner DK (1993). Mammalian glucokinase. Annu. Rev. Nutr. 13: 463-496. http://dx.doi.org/10.1146/annurev.nu.13.070193.002335 PMid:8369155   Riskin-Mashiah S, Younes G, Damti A and Auslender R (2009). First-trimester fasting hyperglycemia and adverse pregnancy outcomes. Diabetes Care 32: 1639-1643. http://dx.doi.org/10.2337/dc09-0688 PMid:19549728 PMCid:2732138   Rivero K, Portal VL, Vieira M and Behle I (2008). Prevalence of the impaired glucose metabolism and its association with risk factors for coronary artery disease in women with gestational diabetes. Diabetes Res. Clin. Pract. 79: 433-437. http://dx.doi.org/10.1016/j.diabres.2007.10.015 PMid:18045723   Rose CS, Ek J, Urhammer SA, Glumer C, et al. (2005). A -30G>A polymorphism of the beta-cell-specific glucokinase promoter associates with hyperglycemia in the general population of whites. Diabetes 54: 3026-3031. http://dx.doi.org/10.2337/diabetes.54.10.3026 PMid:16186409   Rosenberg TJ, Garbers S, Lipkind H and Chiasson MA (2005). Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: differences among 4 racial/ethnic groups. Am. J. Public. Health 95: 1545-1551. http://dx.doi.org/10.2105/AJPH.2005.065680 PMid:16118366 PMCid:1449396   Rubio-Cabezas O, Klupa T and Malecki MT (2011). Permanent neonatal diabetes mellitus - the importance of diabetes differential diagnosis in neonates and infants. Eur. J. Clin. Invest. 41: 323-333. http://dx.doi.org/10.1111/j.1365-2362.2010.02409.x PMid:21054355   Ruzzo A, Andreoni F and Magnani M (1998). Structure of the human hexokinase type I gene and nucleotide sequence of the 5' flanking region. Biochem. J. 331 (Pt 2): 607-613. PMid:9531504 PMCid:1219395   Santos IC, Daga DR, Frigeri HR, Rea RR, et al. (2010a). The functional polymorphisms -429T>C and -374T>A of the RAGE gene promoter are not associated with gestational diabetes in Euro-Brazilians. Genet. Mol. Res. 9: 1130-1135. http://dx.doi.org/10.4238/vol9-2gmr817 PMid:20568058   Santos IC, Frigeri HR, Rea RR, Almeida AC, et al. (2010b). The glucokinase gene promoter polymorphism -30G>A (rs1799884) is associated with fasting glucose in healthy pregnant women but not with gestational diabetes. Clin. Chim. Acta 411: 892-893. http://dx.doi.org/10.1016/j.cca.2010.03.011 PMid:20227404   Schmidt MI, Matos MC, Reichelt AJ, Forti AC, et al. (2000). Prevalence of gestational diabetes mellitus - do the new WHO criteria make a difference? Brazilian Gestational Diabetes Study Group. Diabet. Med. 17: 376-380. http://dx.doi.org/10.1046/j.1464-5491.2000.00257.x PMid:10872537   Souza RL, Mikami LR, Maegawa RO and Chautard-Freire-Maia EA (2005). Four new mutations in the BCHE gene of human butyrylcholinesterase in a Brazilian blood donor sample. Mol. Genet. Metab. 84: 349-353. http://dx.doi.org/10.1016/j.ymgme.2004.12.005 PMid:15781196   Stoffel M, Froguel P, Takeda J, Zouali H, et al. (1992). Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus. Proc. Natl. Acad. Sci. U. S. A. 89: 7698-7702. http://dx.doi.org/10.1073/pnas.89.16.7698 PMid:1502186 PMCid:49778   Tinto N, Zagari A, Capuano M, De Simone A, et al. (2008). Glucokinase gene mutations: structural and genotype-phenotype analyses in MODY children from South Italy. PLoS One 3: e1870.   Weedon MN, Frayling TM, Shields B, Knight B, et al. (2005). Genetic regulation of birth weight and fasting glucose by a common polymorphism in the islet cell promoter of the glucokinase gene. Diabetes 54: 576-581. http://dx.doi.org/10.2337/diabetes.54.2.576 PMid:15677518